Brief: Arovella Therapeutics Says Thomas Duthy Will Be Retiring As Non-Executive Director & Chairman
30/06/2025 02:40
June 30 (Reuters) - Arovella Therapeutics Ltd ALA.AX: THOMAS DUTHY WILL BE RETIRING AS A NON-EXECUTIVE DIRECTOR AND CHAIRMAN THOMAS DUTHY TO RETIRE AS CHAIRMAN EFFECTIVE 1 JULY 2025 ELIZABETH STONER TO SERVE AS INTERIM CHAIR Further company coverage: ALA.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO